vs

Side-by-side financial comparison of IF Bancorp, Inc. (IROQ) and SS Innovations International, Inc. (SSII). Click either name above to swap in a different company.

SS Innovations International, Inc. is the larger business by last-quarter revenue ($14.5M vs $7.3M, roughly 2.0× IF Bancorp, Inc.). IF Bancorp, Inc. runs the higher net margin — 18.1% vs -17.0%, a 35.1% gap on every dollar of revenue. On growth, SS Innovations International, Inc. posted the faster year-over-year revenue change (79.1% vs 16.8%). IF Bancorp, Inc. produced more free cash flow last quarter ($1.7M vs $-3.2M). Over the past eight quarters, SS Innovations International, Inc.'s revenue compounded faster (99.9% CAGR vs 16.5%).

U.S. Bancorp is an American multinational banking institution headquartered in Minneapolis, Minnesota and incorporated in Delaware. It is the 5th-largest bank in the United States as of 2025. As the largest bank in the Midwestern United States, it is considered systemically important by the Financial Stability Board. It is the parent company of its primary operating entity, U.S. Bank National Association, which does business as U.S. Bank. The company provides banking, investment, mortgage, tr...

SS Innovations International, Inc. is a global medical technology enterprise specializing in the research, development and manufacturing of innovative surgical robotic systems. It provides high-precision, accessible robotic platforms for minimally invasive surgery, catering to healthcare facilities across multiple regions to boost surgical outcomes and cut procedural burdens.

IROQ vs SSII — Head-to-Head

Bigger by revenue
SSII
SSII
2.0× larger
SSII
$14.5M
$7.3M
IROQ
Growing faster (revenue YoY)
SSII
SSII
+62.2% gap
SSII
79.1%
16.8%
IROQ
Higher net margin
IROQ
IROQ
35.1% more per $
IROQ
18.1%
-17.0%
SSII
More free cash flow
IROQ
IROQ
$5.0M more FCF
IROQ
$1.7M
$-3.2M
SSII
Faster 2-yr revenue CAGR
SSII
SSII
Annualised
SSII
99.9%
16.5%
IROQ

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
IROQ
IROQ
SSII
SSII
Revenue
$7.3M
$14.5M
Net Profit
$1.3M
$-2.5M
Gross Margin
43.9%
Operating Margin
24.9%
-3.7%
Net Margin
18.1%
-17.0%
Revenue YoY
16.8%
79.1%
Net Profit YoY
8.9%
-28.5%
EPS (diluted)
$0.41
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IROQ
IROQ
SSII
SSII
Q4 25
$7.3M
$14.5M
Q3 25
$7.3M
$12.8M
Q2 25
$6.9M
$10.0M
Q1 25
$6.4M
$5.1M
Q4 24
$6.3M
$8.1M
Q3 24
$6.2M
$4.4M
Q2 24
$5.7M
$4.5M
Q1 24
$5.4M
$3.6M
Net Profit
IROQ
IROQ
SSII
SSII
Q4 25
$1.3M
$-2.5M
Q3 25
$1.4M
$-3.7M
Q2 25
$1.4M
$-256.7K
Q1 25
$1.0M
$-5.7M
Q4 24
$1.2M
$-1.9M
Q3 24
$633.0K
$-3.2M
Q2 24
$431.0K
$-4.1M
Q1 24
$708.0K
$-9.8M
Gross Margin
IROQ
IROQ
SSII
SSII
Q4 25
43.9%
Q3 25
48.1%
Q2 25
59.1%
Q1 25
21.2%
Q4 24
48.9%
Q3 24
52.8%
Q2 24
31.9%
Q1 24
20.0%
Operating Margin
IROQ
IROQ
SSII
SSII
Q4 25
24.9%
-3.7%
Q3 25
26.0%
-14.3%
Q2 25
29.1%
1.0%
Q1 25
21.7%
-115.6%
Q4 24
26.8%
-22.7%
Q3 24
13.7%
-73.1%
Q2 24
9.3%
-90.9%
Q1 24
17.6%
-270.3%
Net Margin
IROQ
IROQ
SSII
SSII
Q4 25
18.1%
-17.0%
Q3 25
19.0%
-29.0%
Q2 25
21.0%
-2.6%
Q1 25
15.8%
-111.0%
Q4 24
19.4%
-23.7%
Q3 24
10.2%
-74.0%
Q2 24
7.6%
-91.8%
Q1 24
13.1%
-270.5%
EPS (diluted)
IROQ
IROQ
SSII
SSII
Q4 25
$0.41
$-0.01
Q3 25
$0.43
$-0.02
Q2 25
$0.48
$0.00
Q1 25
$0.31
$-0.03
Q4 24
$0.38
$-0.01
Q3 24
$0.20
$-0.02
Q2 24
$0.15
$-0.02
Q1 24
$0.22
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IROQ
IROQ
SSII
SSII
Cash + ST InvestmentsLiquidity on hand
$8.8M
$3.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$87.4M
$38.2M
Total Assets
$830.4M
$74.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IROQ
IROQ
SSII
SSII
Q4 25
$8.8M
$3.2M
Q3 25
$8.0M
$5.7M
Q2 25
$20.1M
$11.4M
Q1 25
$8.9M
$15.9M
Q4 24
$5.9M
$466.5K
Q3 24
$7.8M
$220.4K
Q2 24
$9.6M
$608.2K
Q1 24
$16.1M
$948.1K
Stockholders' Equity
IROQ
IROQ
SSII
SSII
Q4 25
$87.4M
$38.2M
Q3 25
$84.5M
$39.6M
Q2 25
$81.8M
$42.0M
Q1 25
$78.9M
$40.6M
Q4 24
$75.9M
$13.5M
Q3 24
$78.8M
$13.7M
Q2 24
$73.9M
$14.8M
Q1 24
$72.4M
$16.7M
Total Assets
IROQ
IROQ
SSII
SSII
Q4 25
$830.4M
$74.2M
Q3 25
$862.3M
$69.6M
Q2 25
$887.7M
$70.0M
Q1 25
$879.1M
$63.5M
Q4 24
$885.1M
$42.4M
Q3 24
$893.4M
$39.0M
Q2 24
$887.7M
$35.7M
Q1 24
$905.0M
$35.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IROQ
IROQ
SSII
SSII
Operating Cash FlowLast quarter
$1.8M
$-1.5M
Free Cash FlowOCF − Capex
$1.7M
$-3.2M
FCF MarginFCF / Revenue
23.7%
-22.3%
Capex IntensityCapex / Revenue
0.9%
11.8%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$9.5M
$-22.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IROQ
IROQ
SSII
SSII
Q4 25
$1.8M
$-1.5M
Q3 25
$-539.0K
$-7.5M
Q2 25
$6.8M
$-3.5M
Q1 25
$1.8M
$-6.1M
Q4 24
$-155.0K
$-3.3M
Q3 24
$2.2M
$-2.5M
Q2 24
$2.3M
$-1.0M
Q1 24
$19.0K
$-2.7M
Free Cash Flow
IROQ
IROQ
SSII
SSII
Q4 25
$1.7M
$-3.2M
Q3 25
$-582.0K
$-8.2M
Q2 25
$6.5M
$-3.8M
Q1 25
$1.8M
$-7.0M
Q4 24
$-226.0K
$-3.4M
Q3 24
$2.1M
$-4.2M
Q2 24
$2.0M
$-3.1M
Q1 24
$-67.0K
$-2.8M
FCF Margin
IROQ
IROQ
SSII
SSII
Q4 25
23.7%
-22.3%
Q3 25
-7.9%
-64.1%
Q2 25
95.1%
-37.7%
Q1 25
28.2%
-136.2%
Q4 24
-3.6%
-41.7%
Q3 24
33.6%
-96.9%
Q2 24
35.7%
-69.5%
Q1 24
-1.2%
-76.9%
Capex Intensity
IROQ
IROQ
SSII
SSII
Q4 25
0.9%
11.8%
Q3 25
0.6%
5.9%
Q2 25
3.5%
3.2%
Q1 25
0.4%
17.0%
Q4 24
1.1%
1.5%
Q3 24
1.2%
38.8%
Q2 24
4.3%
46.8%
Q1 24
1.6%
3.5%
Cash Conversion
IROQ
IROQ
SSII
SSII
Q4 25
1.36×
Q3 25
-0.39×
Q2 25
4.69×
Q1 25
1.81×
Q4 24
-0.13×
Q3 24
3.42×
Q2 24
5.30×
Q1 24
0.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IROQ
IROQ

Segment breakdown not available.

SSII
SSII

System Sales$13.4M92%
Other$1.2M8%

Related Comparisons